Covid-19 could drive biotech stocks for years to come, experts say, as investors try to pinpoint the next big winner to churn out a vaccine or treatment. The post Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To Come appeared first on Investor's Business Daily.